nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—CYP3A4—Rifampicin—leprosy	0.211	0.548	CbGbCtD
Desvenlafaxine—CYP3A4—Dapsone—leprosy	0.174	0.452	CbGbCtD
Desvenlafaxine—Proteinuria—Dapsone—leprosy	0.0287	0.0467	CcSEcCtD
Desvenlafaxine—Protein urine present—Dapsone—leprosy	0.0283	0.0461	CcSEcCtD
Desvenlafaxine—Sexual dysfunction—Thalidomide—leprosy	0.0231	0.0375	CcSEcCtD
Desvenlafaxine—Interstitial lung disease—Thalidomide—leprosy	0.0183	0.0297	CcSEcCtD
Desvenlafaxine—Myocardial ischaemia—Thalidomide—leprosy	0.0161	0.0261	CcSEcCtD
Desvenlafaxine—Proteinuria—Thalidomide—leprosy	0.0147	0.0239	CcSEcCtD
Desvenlafaxine—Protein urine present—Thalidomide—leprosy	0.0145	0.0236	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Dapsone—leprosy	0.0145	0.0235	CcSEcCtD
Desvenlafaxine—Musculoskeletal stiffness—Thalidomide—leprosy	0.0144	0.0234	CcSEcCtD
Desvenlafaxine—Bone disorder—Thalidomide—leprosy	0.0143	0.0233	CcSEcCtD
Desvenlafaxine—Tinnitus—Dapsone—leprosy	0.0118	0.0192	CcSEcCtD
Desvenlafaxine—Vision blurred—Dapsone—leprosy	0.0104	0.0169	CcSEcCtD
Desvenlafaxine—Libido decreased—Thalidomide—leprosy	0.0101	0.0165	CcSEcCtD
Desvenlafaxine—Vertigo—Dapsone—leprosy	0.00991	0.0161	CcSEcCtD
Desvenlafaxine—Hyponatraemia—Thalidomide—leprosy	0.00942	0.0153	CcSEcCtD
Desvenlafaxine—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00938	0.0153	CcSEcCtD
Desvenlafaxine—Disturbance in sexual arousal—Thalidomide—leprosy	0.00931	0.0151	CcSEcCtD
Desvenlafaxine—Tachycardia—Dapsone—leprosy	0.00879	0.0143	CcSEcCtD
Desvenlafaxine—Liver function test abnormal—Thalidomide—leprosy	0.00866	0.0141	CcSEcCtD
Desvenlafaxine—Orthostatic hypotension—Thalidomide—leprosy	0.00857	0.0139	CcSEcCtD
Desvenlafaxine—Breast disorder—Thalidomide—leprosy	0.00848	0.0138	CcSEcCtD
Desvenlafaxine—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00845	0.0137	CcSEcCtD
Desvenlafaxine—Insomnia—Dapsone—leprosy	0.00814	0.0132	CcSEcCtD
Desvenlafaxine—Erectile dysfunction—Thalidomide—leprosy	0.00747	0.0121	CcSEcCtD
Desvenlafaxine—Photosensitivity reaction—Thalidomide—leprosy	0.0074	0.012	CcSEcCtD
Desvenlafaxine—Weight increased—Thalidomide—leprosy	0.00738	0.012	CcSEcCtD
Desvenlafaxine—Weight decreased—Thalidomide—leprosy	0.00733	0.0119	CcSEcCtD
Desvenlafaxine—Stevens-Johnson syndrome—Thalidomide—leprosy	0.00717	0.0117	CcSEcCtD
Desvenlafaxine—Acute coronary syndrome—Thalidomide—leprosy	0.00713	0.0116	CcSEcCtD
Desvenlafaxine—Myocardial infarction—Thalidomide—leprosy	0.00709	0.0115	CcSEcCtD
Desvenlafaxine—Epistaxis—Thalidomide—leprosy	0.00682	0.0111	CcSEcCtD
Desvenlafaxine—Urinary tract disorder—Thalidomide—leprosy	0.00641	0.0104	CcSEcCtD
Desvenlafaxine—Urethral disorder—Thalidomide—leprosy	0.00636	0.0103	CcSEcCtD
Desvenlafaxine—Erythema multiforme—Thalidomide—leprosy	0.00614	0.00998	CcSEcCtD
Desvenlafaxine—Eye disorder—Thalidomide—leprosy	0.00606	0.00986	CcSEcCtD
Desvenlafaxine—Tinnitus—Thalidomide—leprosy	0.00605	0.00984	CcSEcCtD
Desvenlafaxine—Cardiac disorder—Thalidomide—leprosy	0.00602	0.00979	CcSEcCtD
Desvenlafaxine—Angiopathy—Thalidomide—leprosy	0.00589	0.00958	CcSEcCtD
Desvenlafaxine—Immune system disorder—Thalidomide—leprosy	0.00586	0.00953	CcSEcCtD
Desvenlafaxine—Mediastinal disorder—Thalidomide—leprosy	0.00585	0.00951	CcSEcCtD
Desvenlafaxine—Chills—Thalidomide—leprosy	0.00582	0.00947	CcSEcCtD
Desvenlafaxine—Alopecia—Thalidomide—leprosy	0.00573	0.00933	CcSEcCtD
Desvenlafaxine—Vomiting—Dapsone—leprosy	0.00573	0.00931	CcSEcCtD
Desvenlafaxine—Mental disorder—Thalidomide—leprosy	0.00568	0.00925	CcSEcCtD
Desvenlafaxine—Malnutrition—Thalidomide—leprosy	0.00565	0.00919	CcSEcCtD
Desvenlafaxine—Headache—Dapsone—leprosy	0.00564	0.00918	CcSEcCtD
Desvenlafaxine—Tension—Thalidomide—leprosy	0.00554	0.00902	CcSEcCtD
Desvenlafaxine—Dysgeusia—Thalidomide—leprosy	0.00553	0.009	CcSEcCtD
Desvenlafaxine—Nervousness—Thalidomide—leprosy	0.00549	0.00892	CcSEcCtD
Desvenlafaxine—Nausea—Dapsone—leprosy	0.00535	0.0087	CcSEcCtD
Desvenlafaxine—Vision blurred—Thalidomide—leprosy	0.00532	0.00866	CcSEcCtD
Desvenlafaxine—Tremor—Thalidomide—leprosy	0.00529	0.00861	CcSEcCtD
Desvenlafaxine—Angioedema—Thalidomide—leprosy	0.00516	0.00839	CcSEcCtD
Desvenlafaxine—Vertigo—Thalidomide—leprosy	0.00507	0.00825	CcSEcCtD
Desvenlafaxine—Syncope—Thalidomide—leprosy	0.00507	0.00824	CcSEcCtD
Desvenlafaxine—Palpitations—Thalidomide—leprosy	0.00499	0.00812	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Thalidomide—leprosy	0.00496	0.00807	CcSEcCtD
Desvenlafaxine—Convulsion—Thalidomide—leprosy	0.00489	0.00796	CcSEcCtD
Desvenlafaxine—Hypertension—Thalidomide—leprosy	0.00488	0.00793	CcSEcCtD
Desvenlafaxine—Anxiety—Thalidomide—leprosy	0.00479	0.00779	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00478	0.00777	CcSEcCtD
Desvenlafaxine—Dry mouth—Thalidomide—leprosy	0.0047	0.00765	CcSEcCtD
Desvenlafaxine—Shock—Thalidomide—leprosy	0.00454	0.00738	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Thalidomide—leprosy	0.00452	0.00735	CcSEcCtD
Desvenlafaxine—Tachycardia—Thalidomide—leprosy	0.0045	0.00732	CcSEcCtD
Desvenlafaxine—Skin disorder—Thalidomide—leprosy	0.00448	0.00728	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Thalidomide—leprosy	0.00446	0.00725	CcSEcCtD
Desvenlafaxine—Insomnia—Thalidomide—leprosy	0.00417	0.00678	CcSEcCtD
Desvenlafaxine—Paraesthesia—Thalidomide—leprosy	0.00414	0.00673	CcSEcCtD
Desvenlafaxine—Somnolence—Thalidomide—leprosy	0.0041	0.00667	CcSEcCtD
Desvenlafaxine—Decreased appetite—Thalidomide—leprosy	0.00401	0.00652	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Thalidomide—leprosy	0.00398	0.00647	CcSEcCtD
Desvenlafaxine—Fatigue—Thalidomide—leprosy	0.00397	0.00646	CcSEcCtD
Desvenlafaxine—Constipation—Thalidomide—leprosy	0.00394	0.00641	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Thalidomide—leprosy	0.0034	0.00552	CcSEcCtD
Desvenlafaxine—Asthenia—Thalidomide—leprosy	0.00331	0.00538	CcSEcCtD
Desvenlafaxine—Diarrhoea—Thalidomide—leprosy	0.00315	0.00513	CcSEcCtD
Desvenlafaxine—Dizziness—Thalidomide—leprosy	0.00305	0.00496	CcSEcCtD
Desvenlafaxine—Vomiting—Thalidomide—leprosy	0.00293	0.00477	CcSEcCtD
Desvenlafaxine—Rash—Thalidomide—leprosy	0.00291	0.00473	CcSEcCtD
Desvenlafaxine—Dermatitis—Thalidomide—leprosy	0.0029	0.00472	CcSEcCtD
Desvenlafaxine—Headache—Thalidomide—leprosy	0.00289	0.0047	CcSEcCtD
Desvenlafaxine—Nausea—Thalidomide—leprosy	0.00274	0.00445	CcSEcCtD
